High rate of durable complete remission in follicular lymphoma after CD19 CAR-T cell immunotherapy

Patients with follicular lymphoma (FL) with early relapse after initial chemoimmunotherapy, refractory disease, or histologic transformation (tFL) have limited progression-free and overall survival. We report efficacy and long-term follow-up of 21 patients with relapsed/refractory (R/R) FL (n = 8) a...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Blood
Päätekijät: Hirayama, Alexandre V., Gauthier, Jordan, Hay, Kevin A., Voutsinas, Jenna M., Wu, Qian, Pender, Barbara S., Hawkins, Reed M., Vakil, Aesha, Steinmetz, Rachel N., Riddell, Stanley R., Maloney, David G., Turtle, Cameron J.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: American Society of Hematology 2019
Aiheet:
Immunobiology and Immunotherapy
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6695558/
https://ncbi.nlm.nih.gov/pubmed/31648294
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood.2019000905
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia